EUCTR2007-004686-18-FR进行中（未招募）1 期
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1% Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.
Bausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH0 个研究点目标入组 123 人开始时间: 2007年11月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 123
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female patients, age = 18 years
- •Planned to undergo cataract surgery on one eye by phaco-emulsification with posterior chamber intraocular lens and using topical anaesthesia.
- •Pre-operative flare = 15 ph/ms, measured with the laser flare meter (LFM) without pharmacological pupil dilation, within the 2 months preoperatively
- •Subject must read, understand and signed the Inform Consent Form.
- •Women of childbearing potential, must have negative urine pregnancy test at baseline.
- •Subject willing to comply with all treatment and follow-up procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Inflammatory and/or infectious pathology of the eye and its adnexa
- •History of post-operative intraocular infection in the fellow eye
- •Glaucoma in the study eye
- •Post-traumatic cataract in the study eye
- •Exfoliative syndrome
- •History of uveitis
- •Any progressive pathology requiring the use of topical or systemic anti-inflammatory or anti-infectious agents
- •Immunodepression
- •History of intolerance to the tested drugs and to any NSAI drug
- •Monocular patients (for any other reason than cataract)
- •Patients treated with local or systemic anti-inflammatory drugs within 10 days prior to inclusion
- •In the case of cataract surgery on the 2nd eye, if the subject was already included inthe study for the 1st eye, teh 2nd eye cannot be considered another study eye;
- •Pregnant and lactating women
- •Active peptic ulcer
- •Severe hepatocellular or renal impairment
- •Subject who take acetylsalicylic acid at doses >100mg and cannot discontinue usage during the study.
- •Asthma linked to acetylsalicylic acid or NSAI
- •Surgery planned during the study other than cataract surgery or cataract surgery on the fellow eye.
- •Subjects who have surgery planned to occur during the course of the study other than cataract surgery on the study eye or cataract surgery on the fellow eye. If surgery is planned to occur for the fellow eye before Visit 5 (Day 30 ± 3 days) is completed, the subject must be excluded.
- •Women sexually active and who do not fall into one of the following categories :
- •Post menopausal / Surgically sterile / Using one birth control methods throughout the duration of the study (Intrauterine device > 14 days - Barrier method, diaphram or condom, with spermicide < 14 days- hormonal contraception, same dose and same formulation for at least 6 months) .
研究者
相似试验
进行中（未招募）
不适用
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1 % Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.Prevention of ocular inflammation in adults patients undergoing cataract surgeryMedDRA version: 9.1Level: HLTClassification code 10030045Term: Ocular infections, inflammations and associated manifestationsEUCTR2007-004686-18-DEDr. Gerhard Mann chem.-pharm. Fabrik GmbH120
进行中（未招募）
不适用
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1% Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.Prevention of ocular inflammation in adults patients undergoing cataract surgery.EUCTR2007-004686-18-PTBausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH120
已完成
不适用
Comparing the Efficacy and Safety of Indomethacin 0.1% Eyedrops versus Ketorolac 0.5% Eyedrops in Ocular Inflammation After Cataract SurgerysurgeryphacoemulsificationEye DiseasesCataractISRCTN03110798Dr. Mann Pharma GmbH, Bausch & Lomb Inc. (Germany)120
进行中（未招募）
不适用
A Multi-center, Double-Masked, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects with Active Non-Infectious Uveitis Involving the Intermediate and/or Posterior Segments of the Eyeon-Infectious Intermediate, Posterior or Pan-uveitisEUCTR2010-022128-63-DEux Biosciences, Inc.180
进行中（未招募）
1 期
A Multi-center, Double-Masked, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects with Active Non-Infectious Intermediate, Posterior or Pan-uveitis - A MC study to assess Efficacy and Safety of Voclosporin in Panuveitison-Infectious Intermediate, Posterior or Pan-uveitisEUCTR2010-022128-63-GBux Biosciences, Inc.180